Research On Production Security Management Of Boya-Seehot Pharmaceutical Corporation In The New Situation

The pharmaceutical industry is closely related to human health and life,and plays an important role in social development and the national economy.In the new situation,the pharmaceutical industry has developed rapidly.Due to the lack of safety management experience and talents,production safety accidents have occurred frequently.From the perspective of pharmaceutical companies,most of the explosive and flammable dangerous chemicals produced and used by them can cause safety accidents if they don't pay sufficient attention.Among them,there are serious and extremely serious accidents,which cause serious impact on people's life and property security,national economy development,and environmental protection etc.Therefore,it is practically significant to strengthen research on the safety management of the pharmaceutical industries.At present,many domestic enterprises have established and implemented safety management systems.However,after implementing the management system,many enterprises have not achieved satisfactory results or anticipated performances.It is controversial to determine whether a management system is effective and which evaluation method should be used.BX Pharmaceutical Co.,Ltd.needs to use large quantities of hazardous chemicals such as thionyl chloride,sulfuric acid,methylene chloride,acetonitrile,chlorosulfonic acid and anisole in the manufacturing process,so it requires high requirements for safe production management.As a consequence,the company is carring out three systems(Quality,Environmental,Occupational Health and Safety Management)certification.This paper studied the current situation of safety management system and combined the three systems(Quality,Environmental,Occupational Health and Safety Management)certification to analyze the defects or deficiencies in the implementation process of safety management system,which may provide improvement suggestions for enterprise safety management,and then provide effective experience to improve the safety management level of domestic pharmaceutical companies and the capacity of analyzing existing problems.